Active Ingredient History
Peripheral blood stem cell transplantation (PBSCT), also called "Peripheral stem cell support", is a method of replacing blood-forming stem cells. Stem cells can be destroyed through cancer treatments such as chemotherapy or radiation, as well as any blood-related diseases, such as leukemia, lymphoma, neuroblastoma and multiple myeloma. PBSCT is now a much more common procedure than its bone marrow harvest equivalent due to the ease and less invasive nature of the procedure. Studies suggest that PBSCT has a better outcome in terms of the number of hematopoietic stem cell yield. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Phase 2)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 2)
Anemia, Refractory (Phase 2)
Antigens, CD20 (Phase 1)
Autoimmune Diseases (Phase 2)
Bone Marrow Cells (Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Burkitt Lymphoma (Phase 3)
Carcinoma (Phase 2)
Cartilage Diseases (Phase 2)
Central Nervous System Neoplasms (Phase 3)
Cerebellar Diseases (Phase 2)
Chordoma (Phase 1)
Chromosome Aberrations (Phase 2)
Chronic Disease (Phase 2)
Colorectal Neoplasms (Phase 1/Phase 2)
Crohn Disease (Phase 1/Phase 2)
Diploidy (Phase 2)
Encephalitis (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fanconi Anemia (Phase 2)
Graft vs Host Disease (Phase 3)
Hamartoma (Phase 2)
Head and Neck Neoplasms (Phase 2)
Hematologic Diseases (Phase 2)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hemoglobinuria, Paroxysmal (Phase 2)
HIV Infections (Phase 2)
Hodgkin Disease (Phase 3)
Infections (Phase 2)
Inflammatory Breast Neoplasms (Phase 2)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 2)
Kidney Neoplasms (Phase 2)
Lambert-Eaton Myasthenic Syndrome (Phase 2)
Leukemia (Phase 3)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 3)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Mast-Cell (Phase 2)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid, Acute (Phase 4)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Neutrophilic, Chronic (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 3)
Leukemia, Prolymphocytic, B-Cell (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 3)
Liver Neoplasms (Phase 1)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, AIDS-Related (Phase 1)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 3)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 2)
Lymphoproliferative Disorders (Phase 2)
Mastocytosis (Phase 2)
Mediastinal Neoplasms (Phase 3)
Melanoma (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 2)
Myasthenia Gravis (Phase 2)
Myelodysplastic Syndromes (Phase 4)
Myeloproliferative Disorders (Phase 3)
Myocardial Infarction (Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neuroblastoma (Phase 3)
Neuromyelitis Optica (Phase 2)
Neutropenia (Phase 3)
Opsoclonus-Myoclonus Syndrome (Phase 2)
Organ Transplantation (Phase 2)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 1/Phase 2)
Plasmablastic Lymphoma (Phase 1/Phase 2)
Plasmacytoma (Phase 2)
Polycythemia Vera (Phase 2)
Precancerous Conditions (Phase 2)
Primary Myelofibrosis (Phase 3)
Prognosis (Phase 2)
Prostatic Neoplasms (Phase 2)
Retinoblastoma (Phase 2)
Rhabdomyosarcoma (Phase 2)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Scleroderma, Systemic (Phase 2)
Severe Combined Immunodeficiency (Phase 2)
Sezary Syndrome (Phase 2)
Shwachman-Diamond Syndrome (Phase 2)
Smoldering Multiple Myeloma (Phase 1/Phase 2)
Stiff-Person Syndrome (Phase 2)
Teratoma (Phase 1/Phase 2)
Testicular Neoplasms (Phase 3)
Thrombocythemia, Essential (Phase 2)
Thrombocytopenia (Phase 2)
Tissue Donors (Phase 2)
Translocation, Genetic (Phase 2)
Transplantation (Phase 2)
Transplantation, Autologous (Phase 2)
Transplantation, Homologous (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vaginal Neoplasms (Phase 2)
Vasculitis, Central Nervous System (Phase 2)
Waldenstrom Macroglobulinemia (Phase 3)
Wiskott-Aldrich Syndrome (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
